As of February 2025, the FDA declared that the semaglutide shortage was resolved
It also includes the gastric inhibitory polypeptide GIP/GLP-1 agonist, tirzepatide (Mounjaro)
When you stop, those effects fade, hunger ramps back up, and your body gravitates toward its previous set point
This question should be asked with sensitivity due to the potential of past experience with weight stigma
If things go very well, it might be approved for obesity in mid-2026, but it might take a little bit longer for it to be approved for cardiovascular risk reduction. Beware Grey Market Dupes If you just re-read the abovethat reta wont be available for a whileand are scratching your head because you have a friend who says theyre taking it or youve seen ads online for it, keep in mind that theyre not getting an approved drug at a pharmacy
NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimers diseases